Business
Audit update
Audit update.
About this update from Metir Plc
[{"type":"text","content":"\n\n15 May 2023\n \nMicrosaic Systems plc\n \n(\"Microsaic\" or the \"Company\")\n \nAudit update\n \n \nMicrosaic Systems plc (AIM: MSYS), the developer of micro-electronic instruments and analytical solutions, wishes to provide an update on the expected date of its audited results for the year to 31 December 2022 (the \"FY22 Results\").\n \nOn 18 April 2023, the Company announced that it expected to release its FY22 Results during the first half of May 2023. As the audit is taking longer than initially anticipated, the FY22 Results are now expected to be published on or before 30 June 2023.\nEnquiries:\n \n\n\n\nMicrosaic Systems plc\n\n\n+44 (0) 734 0055 648\n\n\n\n\nGerry Brandon, Acting Executive Chairman\n\n\n \n\n\n\n\n\n\n\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\n\n\n+44 (0)20 7496 3000\n\n\n\n\nAubrey Powell / George Tzimas\n\n\n \n\n\n\n\n\n\n\n \n\n\n\n\nTurner Pope Investments (TPI) Limited (Joint Broker)\nAndy Thacker / James Pope\n\n\n\n+44 (0) 20 3657 0050\n\n\n\n\n\n\n\n \n\n\n\n \nMarket Abuse Regulation (MAR) Disclosure\nThis announcement contains inside information as stipulated under the UK version of the market abuse regulation no 596/2014 which is part of English law by virtue of the European (withdrawal) act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.\n \nAbout Microsaic Systems\nMicrosaic floated on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested c. £30m over 20 years of development, Microsaic has a robust and innovative patent portfolio in cutting-edge technology designed and developed for \"Industry 4.0\" application. Microsaic serves markets in Human Health, Environmental Health and Diversified Industries. Microsaic's system solutions enable analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous MS detection data at multiple steps in the process workflow.\n \nMicrosaic's products and systems are commercially available through global ...